Cancer/testis antigen family 45, member a5

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
CT45A5
Identifiers
Aliases CT45A5, CT45.5, CT455, cancer/testis antigen family 45, member A5, cancer/testis antigen family 45 member A5, CT45A3, CT45-3, CT45-6, CT45A7, CT45A6, CT45A4, CT45-4
External IDs HomoloGene: 133073 GeneCards: CT45A5
Gene location (Human)
X chromosome (human)
Chr. X chromosome (human)[1]
X chromosome (human)
Genomic location for CT45A5
Genomic location for CT45A5
Band Xq26.3 Start 135,777,130 bp[1]
End 135,785,298 bp[1]
Orthologs
Species Human Mouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_001007551
NM_001172288

n/a

RefSeq (protein)

n/a

Location (UCSC) Chr X: 135.78 – 135.79 Mb n/a
PubMed search [2] n/a
Wikidata
View/Edit Human

Cancer/testis antigen family 45, member A5 is a protein in humans that is encoded by the CT45A5 gene. [3]

This gene represents one of a cluster of six similar genes located on the q arm of chromosome X. The genes in this cluster encode members of the cancer/testis (CT) family of antigens, and are distinct from other CT antigens. These antigens are thought to be novel therapeutic targets for human cancers. Alternative splicing results in multiple transcript variants. A related pseudogene has been identified on chromosome 5. [provided by RefSeq, May 2010].

References

  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000228836 - Ensembl, May 2017
  2. ^ "Human PubMed Reference:".
  3. ^ "Entrez Gene: Cancer/testis antigen family 45, member A5". Retrieved 2012-11-04.

Further reading


Retrieved from "https://en.wikipedia.org/w/index.php?title=Cancer/testis_antigen_family_45,_member_a5&oldid=851718569"
This content was retrieved from Wikipedia : http://en.wikipedia.org/wiki/Cancer/testis_antigen_family_45,_member_a5
This page is based on the copyrighted Wikipedia article "Cancer/testis antigen family 45, member a5"; it is used under the Creative Commons Attribution-ShareAlike 3.0 Unported License (CC-BY-SA). You may redistribute it, verbatim or modified, providing that you comply with the terms of the CC-BY-SA